European Resuscitation Council Guidelines for Resuscitation: 2018 update – antiarrhythmic drugs for cardiac arrest
File(s)
Accepted version
Author(s)
Type
Journal Article
Abstract
This European Resuscitation Council (ERC) Guidelines for Resuscitation 2018 update is focused on the role of antiarrhythmic drugs during advanced life support for cardiac arrest with shock refractory ventricular fibrillation/pulseless ventricular tachycardia in adults, children and infants. This update follows the publication of the International Liaison Committee on Resuscitation (ILCOR) 2018 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations (CoSTR). The ILCOR CoSTR suggests that any beneficial effects of amiodarone or lidocaine are similar. This ERC update does not make any major changes to the recommendations for the use of antiarrhythmic drugs during advanced life support for shock refractory cardiac arrest.
Date Issued
2019-01-01
Date Acceptance
2018-11-23
Citation
Resuscitation, 2019, 134, pp.99-103
ISSN
0300-9572
Publisher
Elsevier BV
Start Page
99
End Page
103
Journal / Book Title
Resuscitation
Volume
134
Copyright Statement
© 2018 Elsevier Ltd. All rights reserved. This manuscript is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence http://creativecommons.org/licenses/by-nc-nd/4.0/
Subjects
Advanced life support
Amiodarone
Antiarrhythmic drugs
Cardiopulmonary resuscitation
Guidelines
Heart arrest
Lidocaine
Neonatal life support
Paediatric life support
Pulseless ventricular tachycardia
Ventricular fibrillation
European Resuscitation Council
1103 Clinical Sciences
1117 Public Health And Health Services
Emergency & Critical Care Medicine
Publication Status
Published
Date Publish Online
2018-11-26